CAS: 2150-48-3; 3,6-Bis(Diethylamino)Xanthylium Chloride

上下游产品

CAS号6274-83-5 5-diethylamino-... | CAS号7647-01-0 盐酸 | CAS号64-18-6 甲酸 | CAS号56-81-5 甘油 | CAS号91-68-9 3-羟基-N,N-二乙基苯胺

📜2,2'-亚甲基二[5-(二乙基氨基)苯酚]置于硫酸,Sodium Hydroxide,盐酸,Sodium Nitrite体系中,用 水 用作溶剂,以56%的收率获得派洛宁b
参考文献: 3,6-Disubstituted Xanthylium Salts[fr] Sels De Xanthylium Disubstitués En 3 Et 6
标题: 3,6-Disubstituted Xanthylium Salts[fr] Sels De Xanthylium Disubstitués En 3 Et 6

专利信息

专利号:US-2018312534-A1
优先权日:2015-10-16
标题:Fluorescent anticancer platinum drugs
发明人：SARKAR ARINDAM; MANDAL SWADHIN KUMAR; SENGUPTA ANIRUDDHA; BISWAS GOUTAM; DUTTA PRADIP; SHARMA RUPALI; RAJ JUSTIN PAUL; SURYAVANSHI HEMANT; KUMARI SMITA
权利人:INVICTUS ONCOLOGY PVT LTD
摘要:The present disclosure is in relation to the field of nanotechnology and cancer therapeutics. In particular, the present disclosure relates to fluorescent platinum based compounds. The disclosure further relates to synthesis of said fluorescent platinum based compounds, nanoparticles and compositions comprising said fluorescent platinum based compounds/nanoparticles. The disclosure also relates to methods of managing cancer by the fluorescence changes between aforesaid platinum based compounds and corresponding free ligands, nanoparticles and compositions.

专利号:US-2023097824-A1
优先权日:2020-05-08
标 题:Semi-synthesis and use of racemic hematoxylin
发明人：DURRANT EDWARD E; HEINDL DIETER; HUBER FLORIAN MAURITIUS ERASUMU; KLEIN ERIC; KOSMEDER II JEROME W; VOSS EDGAR
权利人:VENTANA MED SYST INC; ROCHE DIAGNOSTICS OPERATIONS INC
摘要:A racemic hematoxylin formulation is disclosed that includes one or both of a stabilizer compound and an antioxidant. The disclosed composition exhibits sufficient stability to be utilized in an automated staining process. Methods of using and making the stabilized composition also are disclosed.

专利号:US-7888116-B2
优先权日:2004-07-22
标 题 :Uses of notch receptors, notch ligands, and notch modulators in methods related to metabolic diseases
发明人：EGAN JOSEPHINE M; DOYLE MAIRE E
权利人:US HEALTH
摘要:Disclosed are methods for identifying and isolating a precursor cell. Also, disclosed are methods of increasing insulin synthesis from a pancreatic B-cell. Further, disclosed are methods of improving pancreatic B-cell function. Still further, disclosed are methods of preventing or delaying the onset of a metabolic disease, methods of treating or preventing a metabolic disease in a subject, and to compositions for treating or preventing a metabolic disease in a subject in need of such treatment or prevention.

专利号:US-2005202459-A1
优先权日:2003-09-23
标 题 :Intercalation-mediated synthesis of polymers

专利号:US-9408848-B2
优先权日:2008-08-15
标 题 :Fluorescent CDK inhibitors for treatment of cancer
发明人：YENUGONDA VENKATA MAHIDHAR; BROWN MILTON L
权利人:YENUGONDA VENKATA MAHIDHAR; BROWN MILTON L; UNIV GEORGETOWN
摘要:Disclosed are molecules and their synthesis. The fluorescent moiety also facilitates screening, tracking, and pharmacodynamic studies of the drug in a biological system both in vitro and in vivo.

专利号:US-7368560-B2
优先权日:2003-09-23
标题:Intercalation-mediated synthesis of polymers
发明人：HUD NICHOLAS V
权利人:GEORGIA TECH RES INST
摘要:Methods and compositions for synthesizing biopolymers using an intercalator are provided. Aspects provide compositions and methods for synthesizing biopolymers with non-natural backbones or non-natural biopolymer subunits using natural biopolymer templates. Other aspects provide compositions and methods for synthesizing biopolymers using a template with a non-natural backbone on non-natural biopolymer subunits.